Scientists test new nasal spray vaccine to protect babies from RSV
NCT ID NCT03596801
Summary
This early-stage study tested two versions of a new RSV vaccine given as nose drops in young children. The main goals were to check if the weakened virus in the vaccine was safe, if it caused a minor infection to trigger immunity, and how well children's immune systems responded. The study involved 60 children, split into groups based on whether they had previous RSV exposure, and compared the vaccines to a placebo.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RSV INFECTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Johns Hopkins University Center for Immunization Research
Baltimore, Maryland, 21205, United States
Conditions
Explore the condition pages connected to this study.